MENGENAI EPISOD INI
In this episode, we sit down with Dr. Cary Herzberg, OD, FIAOMC, to answer a question many practitioners face: How young can you start orthokeratology treatment? With decades of experience and a practice focused almost entirely on pediatric patients, Dr. Herzberg shares his insights on evaluating readiness, communicating with parents, and managing complex ortho-k cases in very young children. From clinical criteria to mindset, you'll hear firsthand what it takes to confidently treat the youngest—and often most rewarding—ortho-k candidates.
Bahasa Inggeris
Amerika Syarikat
DALAM EPISOD INI
TRANSKRIP 🔗
Are you the producer of this podcast?
Add a podcast transcript
Need Audio-to-Text?
Transcribe with Listen411 in Just 60 Seconds
CARI EPISOD LEPAS
Cari episod lepas bagi The Myopia Mindset.
EPISOD LAIN DALAM PODCAST INI
Welcome back to Myopia News Monthly, our ongoing segment where we grab the biggest stories in myopia management and actually break them down.
Get the full episode, details, video and bonus content on our Substack: https://myopiamindset.substack.com/p/ama-myopia-disease-resolution
Dr. David Ng was a happy general practice OD in 2002. Then he put a retinoscope in front of his three-year-old son.
SUBSCRIBE ON OUR SUBSTACK
https://myopiamindset.substack.com/
New episode alerts in your inbox, early episodes, video podcasts, newsletter, and bonus content you wont find anywher ...
Dr. Jennifer Lyerly walks through the STAR study numbers, the parents who just want the glasses, and the 25-year-old nobody knows what to do with.
Join Us on Substack: full podcast + articles + bonus content
myopiamindset.substack.com
Subscribe on Substack: Weekly podcast + article + bonus content ↓ https://myopiamindset.substack.com
Dr. Carrie Hartigan on building a pediatric-only practice, training a myopia coordinator, winning pediatrician referrals, and why one flat fee changed how she treats every kid.
ABOUT THE SHOW
The ...
The FDA just gave myopia management a second chance.
Last October, Sydnexis’ SYD-101 — the low-dose atropine drop that would be the first FDA-approved pharmaceutical treatment for pediatric progressive myopia — was rejected in a Complete Response Letter that left most of us scratching our heads. ...
Penafian: Podcast dan karya seni yang dibenamkan pada halaman ini adalah daripada The Myopia Mindset, yang merupakan hak milik pemiliknya dan tidak bergabung dengan atau disokong oleh Listen Notes, Inc.
SUNTING
Terima kasih kerana membantu memastikan pangkalan data podcast dalam keadaan terkini.
